Real-World Data Show Efficacy of Risankizumab in Crohn’s

[ad_1]

Risankizumab demonstrates effectiveness in achieving steroid-free clinical remission in the real-world cohort of patients with refractory Crohn’s disease, with a favourable safety profile.
Medscape News UK

[ad_2]

Source link : https://www.medscape.com/viewarticle/real-world-data-show-efficacy-risankizumab-refractory-crohns-2026a1000kgx?src=rss

Author :

Publish date : 2026-06-19 12:00:00

Copyright for syndicated content belongs to the linked Source.